Results 111 to 120 of about 59,209 (259)
Diverticulitis of the Sigmoid Colon with Vesico-Colic Fistula, Treated by Colectomy [PDF]
C. Naunton Morgan
openalex +1 more source
This national cohort study of patients surgically resected for colon cancer, during 2007–2021, compares survival outcomes of patients with and without inflammatory bowel diseases. The main results were that overall survival, recurrence‐free survival and cancer‐specific survival were lower in patients with IBD.
Erik Lundqvist+8 more
wiley +1 more source
I.—Carcinoma of Rectosigmoid Colon with Hepatic Metastases. Partial Colectomy and Insulin Therapy [PDF]
Ronald W. Raven
openalex +1 more source
Temporal Trends in Medical and Surgical Management of Ulcerative Colitis in England: 2003–2020
Colectomy rates in ulcerative colitis have declined over the last two decades, coinciding with increased use of advanced therapies. These trends reflect significant changes in treatment approaches and provide valuable data to support informed decision‐making by patients, clinicians, and healthcare providers.
J. Couch+3 more
wiley +1 more source
ABSTRACT Objectives Virtual Chromoendoscopy (VCE) is pivotal for assessing activity and predicting outcomes in Ulcerative Colitis (UC), though interobserver variability and the need for expertise persist. Artificial intelligence (AI) offers standardized VCE‐based assessment.
Marietta Iacucci+32 more
wiley +1 more source
Patient positioning on the operating table and patient safety: A systematic review and meta‐analysis
Abstract Aim To identify occurrence of harmful incidents related to patient positioning on operating table. Design Systematic review and meta‐analysis. Data Sources Eight databases including Ovid, Medline, Embase, CINAHL, the Cochrane Library, Epistemonikos, Scopus, Web of Science and Google Scholar were systematically searched from the inception of ...
Signe Berit Bentsen+5 more
wiley +1 more source
Three Hundred Cases of Diffuse Ulcerative Colitis Treated by Total Colectomy and Ileo-rectal Anastomosis [PDF]
Stanley Aylett
openalex +1 more source
ABSTRACT Background and Aim The global QUASAR (NCT04033445) clinical program demonstrated the efficacy and safety of guselkumab, a dual‐acting interleukin‐23 p19 subunit inhibitor, as induction and maintenance therapy in participants with moderate to severely active ulcerative colitis (UC).
Baili Chen+12 more
wiley +1 more source
A 27‐year‐old man had ulcerative colitis (UC) 1 year prior and underwent a colectomy and two‐stage ileal pouch‐anal anastomosis for medically refractory UC 6 months ago.
Kentaro Kojima+8 more
doaj +1 more source